The acquisition enhances patient care and extends CLS Health's geographical reach in the Houston area.

Coronary Heart Disease (CHD) prevention nearly twice as effective when using CARDIO inCode
as method to target treatment

Fortifeye Vitamins - Introducing rTG Omega 3 Fish Oil

Study demonstrates efficacy of StatSeal® Advanced Plus Disc use for groin closure following atrial fibrillation ablation procedures to treat patients with irregular heartbeats.

This solution will add cardiac rehab as a new service line for the practice and increase access for patients throughout California's Central Valley.

The program expands virtual cardiac rehabilitation access to five provider service areas in Arizona

The partnership will provide an innovative virtual cardiac recovery service for their patients across Southern Nevada

The agreement will drive the discovery of more effective treatments for cardiovascular disease and development of safer drugs with the preclinical implementation of advanced human heart models

American Heart Association consortium advances development of evidence-based health tech solutions.

The American Heart Association certification recognizes commitment to following the
latest evidence-based treatment guidelines

Modern Heart and Vascular Institute is proud to offer an intensive cardiac rehabilitation program designed to help patients get back to their normal lives after being diagnosed with cardiovascular disease.

Modern Heart and Vascular Institute expands to another location in the greater Houston area and is ready to serve patients with quality care and a preventative approach to medicine.

Recardio Inc., a late stage clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the FDA concurs with Recardio's pivotal Heal-MI Phase 3 trial design with Dutogliptin in Acute Myocardial Infarction.

Receives eighth FDA clearance, releases its next-generation Cardio AI application

Lipid inCode® offers greater diagnostic information for hypercholesterolemia sufferers over current NHS standard

New look and logo to position Radcliffe as a multimedia knowledge network and global market leader for the cardiovascular community.

Cardiologist Dr. Luiza Petre Explains the Critical Need to Live a Heart-Healthy Lifestyle.

Ricardo Bellera, MD, joins Modern Heart and Vascular to provide quality heart and vascular care for adults living and working in The Woodlands, Katy, Humble, and greater Houston, Texas, area

Commencement of regulatory pathway for U.S. market approval

New heart scan technology for the emergency room

Dr. Kenton specializes in non-invasive cardiology, internal medicine, and wellness.

The NIVA|HF investigational algorithm uses proprietary venous waveform technology from VoluMetrix to assess otherwise hard-to-obtain cardiovascular metrics. According to study authors, 'This non-invasive measurement has potential for … prevention of hospital admission in heart failure patients.'

Percy Francisco Morales, MD, joins Modern Heart and Vascular to provide excellent heart health services for adults living and working in Houston, TX, and the surrounding areas.

Accumed Radial is pleased to announce renowned entrepreneur and venture capitalist William (Bill) N. Starling has become an investor and joined the Accumed Radial Board of Directors.

JAPSC now open to submissions

Interventional Cardiology Review (ICR) journal names Dr Peter O'Kane as ICR's new Editor-in-Chief. Dr O'Kane's term begins July 26, 2021.

Jason Powell joins as Non-Executive Director

In this interview, Dr. Rajiv Agarwal (Cardiologist at Modern Heart and Vascular) talks about high blood pressure.

NIVA|HF is an investigational device designed to monitor the venous waveform, a novel physiologic signal, in heart failure patients. As a Breakthrough Device, NIVA|HF will receive pre-market developmental assistance and prioritized regulatory review from FDA. NIVA|HF is the first application of VoluMetrix's proprietary venous waveform technology.